Diabetes may be independent risk factor for hyperkalaemia
- 2 October 2003
- Vol. 327 (7418) , 812
- https://doi.org/10.1136/bmj.327.7418.812
Abstract
EDITOR—Wrenger et al reported severe hyperkalaemia in patients taking spironolactone in combination with angiotensin converting enzyme inhibitors or angiotensin-II antagonists.1 The strikingly high prevalence of diabetes in these patients (80%) is likely to be important. In a study of the prevalence of hyperkalaemia in an unselected diabetic outpatient population we found that hyperkalaemia was …Keywords
This publication has 4 references indexed in Scilit:
- Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 casesBMJ, 2003
- Life-threatening Hyperkalaemia Caused by Angiotensin-converting Enzyme-inhibitor and DiureticsDiabetic Medicine, 1997
- Hyperkalaemia in diabetes: prevalence and associationsPublished by Oxford University Press (OUP) ,1995
- Hyperkalemia in the elderly.1984